Marshall Fordyce sold $664K of Vera Therapeutics (VERA)

Executed Oct 23 2024, disclosed Oct 25 2024, 2 days later.

Value, as filed

$664K

16,465 sh across 2 lots

Executed

Oct 23 2024

the trade date, as filed

Disclosed

Oct 25 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MF Marshall Fordyce PRESIDENT AND CEO profile →

Marshall Fordyce (PRESIDENT AND CEO) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales, 3 filed past the two-business-day deadline), most often in Vera Therapeutics, Inc. (VERA). The largest single filing was $1.8M of VERA (43,050 sh across 2 lots, as filed), executed Jul 7.

The name

VERA Vera Therapeutics, Inc. VERA · Healthcare · 30 filings in 24 months ticker →

Healthcare · Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatme…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Marshall Fordyce in VERA

VERASALE Vera Therapeutics, Inc. $684K
18,500 sh × $37.00
Exec Sep 15
Filed Sep 17 · 4:28 PM ET VERASALE Vera Therapeutics, Inc. $650K
18,500 sh × $35.12
Exec Sep 2
Filed Sep 4 · 4:15 PM ET VERASALE Vera Therapeutics, Inc. $1.8M
43,050 sh across 2 lots
Exec Jul 7
Filed Aug 12 · 6:42 PM ET † VERASALE Vera Therapeutics, Inc. $1.8M
43,050 sh across 2 lots
Exec Jul 7
Filed Jul 9 · 4:45 PM ET VERASALE Vera Therapeutics, Inc. $698K
18,412 sh × $37.93
Exec Jun 23
Filed Aug 12 · 6:41 PM ET † VERASALE Vera Therapeutics, Inc. $698K
18,412 sh × $37.93
Exec Jun 23
Filed Jun 24 · 5:30 PM ET VERASALE Vera Therapeutics, Inc. $680K
18,500 sh across 2 lots
Exec May 12
Filed Aug 12 · 6:39 PM ET † VERASALE Vera Therapeutics, Inc. $680K
18,500 sh across 2 lots
Exec May 12
Filed May 13 · 5:30 PM ET